TY - JOUR
T1 - Exploring the need for overdose prevention centers in England: a qualitative community-based participatory study on the perspectives of people who use drugs in public and semi-public environments
AU - Scher, Benjamin D.
AU - Southwell, Mat
AU - Harris, Magdalena
AU - Stevens, Alex
AU - Chrisinger, Benjamin W.
AU - Humphreys, David K.
AU - Shorter, Gillian W.
PY - 2025/5/2
Y1 - 2025/5/2
N2 - BackgroundOverdose prevention centres (OPCs) have been implemented as a harm reduction response in around 20 countries; with one just opened in the UK. In a context of rising rates of drug-related deaths, this study aimed to assess the need for an OPC in Sandwell, England, by examining the experiences and perspectives of local people who use drugs.MethodsQualitative data were collected through three focus groups, 20 street-based interviews with people who use drugs, and observations from four ethnographic field sessions. This was a community-based participatory project and included community consultation during study design and peer researcher participation during data collection, analysis and dissemination.ResultsFindings evidence how the threat of public and police interaction in semi-public drug use spaces leads to rushed injection practice, hampers poor venous access management, and increases risk of injection-related harms. Participants were enthusiastic about the concept of an OPC and its potential to reduce injecting-related risks, drug-related death, provide safety, and prevent traumatic experiences with police. Participants also highlighted concerns about negative public perceptions of their community, viewing an OPC as a potential solution to improving community relations by reducing drug-related litter.ConclusionsThere is an urgent need for OPC implementation, given current risks from rushed injection practices, the lack of safe spaces, and the increasing presence of nitazenes and other unexpected contaminants in the UK drug supply. The assertion from local people who drugs that an OPC would be an appropriate and effective intervention requires prioritisation by policymakers.
AB - BackgroundOverdose prevention centres (OPCs) have been implemented as a harm reduction response in around 20 countries; with one just opened in the UK. In a context of rising rates of drug-related deaths, this study aimed to assess the need for an OPC in Sandwell, England, by examining the experiences and perspectives of local people who use drugs.MethodsQualitative data were collected through three focus groups, 20 street-based interviews with people who use drugs, and observations from four ethnographic field sessions. This was a community-based participatory project and included community consultation during study design and peer researcher participation during data collection, analysis and dissemination.ResultsFindings evidence how the threat of public and police interaction in semi-public drug use spaces leads to rushed injection practice, hampers poor venous access management, and increases risk of injection-related harms. Participants were enthusiastic about the concept of an OPC and its potential to reduce injecting-related risks, drug-related death, provide safety, and prevent traumatic experiences with police. Participants also highlighted concerns about negative public perceptions of their community, viewing an OPC as a potential solution to improving community relations by reducing drug-related litter.ConclusionsThere is an urgent need for OPC implementation, given current risks from rushed injection practices, the lack of safe spaces, and the increasing presence of nitazenes and other unexpected contaminants in the UK drug supply. The assertion from local people who drugs that an OPC would be an appropriate and effective intervention requires prioritisation by policymakers.
KW - overdose prevention centres
KW - drug consumption rooms
KW - Supervised consumption sites
KW - community-based participatory research
KW - drug consumption environments
KW - risk environment framework
KW - people who use drugs
KW - co-production
U2 - 10.1016/j.drugpo.2025.104816
DO - 10.1016/j.drugpo.2025.104816
M3 - Article
SN - 1873-4758
VL - 140
JO - International Journal of Drug Policy
JF - International Journal of Drug Policy
M1 - 104816
ER -